Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug;85(2):174-211.
doi: 10.1016/j.jinf.2022.04.034. Epub 2022 Apr 23.

High rate of reinfection with the SARS-CoV-2 Omicron variant

Affiliations
Comment

High rate of reinfection with the SARS-CoV-2 Omicron variant

Nhu Ngoc Nguyen et al. J Infect. 2022 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interest The authors have no conflicts of interest to declare relative to the present study. Didier Raoult was a consultant for the Hitachi High-Technologies Corporation, Tokyo, Japan from 2018 to 2020. He is a scientific board member of the Eurofins company and a founder of a microbial culture company (Culture Top). Funding sources had no role in the design and con-duct of the study, the collection, management, analysis, and interpretation of the data, and the preparation, review, or approval of the manuscript.

Figures

Fig 1
Fig. 1
Dynamics of SARS-CoV-2 infections (left axis) and reinfections (right axis) (a) and of major SARS-CoV-2 variants determined (b) in patients diagnosed at IHU Méditerranée Infection, 2020–2022.
Fig 2
Fig. 2
Frequency of reinfection (proportion of infected patients during a given epidemic who had previous infection with SARS-CoV-2, red curve) and estimated risk for reinfection (proportion of patients first infected during a given epidemic who get reinfected at the time the study.

Comment in

  • "Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants".
    Vera-Lise I, Dominik E, Elisabeth R, Kerstin H, Raffael F, Angelika X, Tibor A, Jusztina B, Ursula K, Jochen H, David K, John-Hendrik J. Vera-Lise I, et al. J Infect. 2022 Oct;85(4):e96-e98. doi: 10.1016/j.jinf.2022.07.003. Epub 2022 Jul 8. J Infect. 2022. PMID: 35810939 Free PMC article. No abstract available.

Comment on

References

    1. Dimeglio C., Migueres M., Mansuy J.M., et al. Antibody titers and breakthrough infections with Omicron SARS-CoV-2. J Infect. 2022;84(4):e13–e15. Doi: 10.1016/j.jinf.2022.01.044. - PMC - PubMed
    1. SeyedAlinaghi S., Mirzapour P., Dadras O., et al. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. Eur J Med Res. 2021;26(1):51. Doi:10.1186/s40001-021-00524-8 MLA. - PMC - PubMed
    1. Nguyen N.N., Houhamdi L., Hoang V.T., et al. SARS-CoV-2 reinfection and COVID severity. Emerg Microbes Infect. 2022;11(1):894–901. Doi: 10.1080/22221751.2022.2052358. - PMC - PubMed
    1. Sheehan M.M., Reddy A.J., Rothberg M.B. Reinfection rates among patients who previously tested positive for coronavirus disease 2019: a retrospective cohort study. Clin Infect Dis. 2021;73(10):1882–1886. Doi:10.1093/cid/ciab234. - PMC - PubMed
    1. Pulliam J.R.C., van Schalkwyk C., Govender N., et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa [published online ahead of print, 2022 Mar 15] Science. 2022 eabn4947Doi:10.1126/science.abn4947. - PMC - PubMed

Supplementary concepts